Former Food and Drug Administration Commissioner Scott Gottlieb says opening up patient access to therapies through the Medicare market can play a key role to support a number of patients by implementing a payment-over-time model for high-cost therapies.Gottlieb made the comments during a recent […]
Latest Stories
Has AHIP Changed Opinion on Medicare Drug Price Negotiation?
While American's Health Insurance Plans (AHIP) in the past has been strictly opposed to allowing Medicare negotiate drug prices, the organization's president, Matt Eyles, recently declined to explicitly say insurers opposed the policy, InsideHealthPolicy reports.According to the report, some say […]
Legislators Added to WHCC2020 Keynote Agenda
U.S. legislators Reps. Seth Moulton and Roger Marshall have been added to the keynote slate for the World Health Care Congress 2020 event, set to kick off March 29 in Washington, D.C.Moulton's speech, according to an email, will be centered around how leaders in Washington can bolster mental […]
NPC, Health Affairs Event Draws 350 Experts to Talk Health Spending
The latest event on health spending hosted by the National Pharmaceutical Council (NPC) and Health Affairs brought together 350 health policy experts to explore rising health spending in the U.S.The event, "Health Spending: Moving from Theory to Action," encouraged attendees to focus on […]
Leatham Talks Valuing New Medicines
Certera Vice President and Global Head of Value and Access Oliver Leatham in a recent article published in the European Pharmaceutical Manufacturer looks at the complex issue of valuation for new drugs."How do you assign a value to saving someone’s life? Then, how do you pay the bill? Those are […]
HHS Expands Accelerator Network
The Department of Health and Human Services (HHS) is expanding its innovation accelerator network as it welcomes five new accelerators, Fierce Healthcare reports.The new accelerators are Emory University and Georgia Institute of Technology, Plug and Play Tech Center, University of Missouri […]
NICE Post Reflects on Partnership with CMAC
A recent post on the National Institute for Health and Care Excellence (NICE) looks at the partnership between it and the Charity Medicines Access Coalition (CMAC) through which the pair worked to "identify where changes to NHS practices, that NICE can influence, could benefit patients and […]
MHE Talks with Pearson on Impact of ICER
Managed Healthcare Executive recently caught up with Steve Pearson, founder and president of the Institute for Clinical and Economic Review (ICER), about the company's impact on coverage decisions.Pearson tells MHE the organization takes eight months to review any given topic, and works with a […]
Gottlieb Joins Health Startup’s Board
Former Food and Drug Administration (FDA) commissioner Scott Gottlieb has joined the board of the directors for health technology startup Aetion, Fierce Healthcare reports.The company made the announcement Tuesday, Sept. 17."The widespread adoption of real-world evidence to the development […]
Stakeholders Say Employers Should Get More Active on Cutting Health Costs
Stakeholders during a recent Health Affairs event in Washington suggested that employers should take a more active role in helping reduce health costs, Healthcare Dive reports.Inaction from employers, according to Reed Tuckson, former chief of medical affairs at UnitedHealth Group, would leave […]
